Latest Posts
About This Stock
More About This Stock
Read
Read
On The Fly: Top Stock Stories For Friday, June 29, 2018

Article By:
The Fly
Friday, June 29, 2018 11:49 PM EST
Stocks opened in positive territory after taking their cue from European and Asian markets, which traded higher overnight. Here is a brief roundup of notable economic events, company news and the major movers of the week.
JPMorgan Upgrades Acceleron To Overweight Ahead Of Luspatercept Data

Article By:
The Fly
Monday, February 26, 2018 9:07 AM EST
JPMorgan analyst Eric Joseph upgraded Acceleron Pharma to Overweight from Neutral and raised his price target for the shares to $52 from $33 ahead of pivotal data for lead asset luspatercept in myelodysplastic syndrome and beta-thalassemia.
In this article: XLRN